{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:03Z","timestamp":1793978883707,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077091"],"award-info":[{"award-number":["22077091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2026NSFSC0561"],"award-info":[{"award-number":["2026NSFSC0561"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119223","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T22:20:35Z","timestamp":1786227635000},"page":"119223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and synthesis of 6-benzyloxybenzo[c]thiophen-1(3H)-ones as selective monoamine oxidase-B inhibitors with antioxidant and anti-neuroinflammatory activities against Parkinson's disease"],"prefix":"10.1016","volume":"319","author":[{"given":"Shiqin","family":"Cong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingning","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6565-6073","authenticated-orcid":false,"given":"Yong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119223_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2026.119223_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","article-title":"Epidemiology of Parkinson's disease","volume":"172","author":"Elbaz","year":"2016","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.ejmech.2026.119223_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.ejmech.2026.119223_bib4","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119223_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainresbull.2020.12.017","article-title":"Research on developing drugs for Parkinson's disease","volume":"168","author":"Zhang","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2026.119223_bib6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1586\/14737175.4.4.589","article-title":"Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo)","volume":"4","author":"Silver","year":"2004","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2026.119223_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","article-title":"Monoamine oxidase: from genes to behavior","volume":"22","author":"Shih","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119223_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.parkreldis.2020.04.012","article-title":"Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: a randomized, double-blind, placebo-controlled, phase II\/III study","volume":"75","author":"Hattori","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejmech.2026.119223_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/17460441.2019.1637415","article-title":"Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?","volume":"14","author":"Guglielmi","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119223_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s13311-021-01097-4","article-title":"KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson's disease","volume":"18","author":"Nam","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2026.119223_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav0316","article-title":"Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease","volume":"5","author":"Park","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119223_bib12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson's disease","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2026.119223_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/antiox9070597","article-title":"The role of oxidative stress in Parkinson's disease","volume":"9","author":"Chang","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2026.119223_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4784268","article-title":"Linking Neuroinflammation and Neurodegeneration in Parkinson's disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ejmech.2026.119223_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101618","article-title":"Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease","volume":"78","author":"Kip","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119223_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejmech.2019.04.016","article-title":"Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease","volume":"173","author":"Tao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib17","first-page":"1","article-title":"Multi-target monoamine oxidase-B (MAO-B) inhibitors in the treatment of Parkinson's disease","volume":"72","author":"Mateev","year":"2025","journal-title":"Pharmacia"},{"key":"10.1016\/j.ejmech.2026.119223_bib18","first-page":"1","article-title":"Potential of MAO-B inhibitors with multi-target inhibition and antioxidant properties for the treatment of neurodegenerative disorders","volume":"26","author":"Moataz","year":"2026","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib19","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1021\/acs.jmedchem.0c00887","article-title":"From seeds of apium graveolens linn. to a cerebral ischemia medicine: the long journey of 3-n-butylphthalide","volume":"63","author":"Marco-Contelles","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2010.03.053","article-title":"dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease","volume":"475","author":"Huang","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2026.119223_bib21","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.neurobiolaging.2011.03.007","article-title":"Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease","volume":"33","author":"Xiong","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2026.119223_bib22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bmcl.2013.01.003","article-title":"Inhibition of monoamine oxidase by phthalide analogues","volume":"23","author":"Strydom","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119223_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105623","article-title":"6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson's disease treatment","volume":"120","author":"Song","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/jpet.104.070334","article-title":"Serofendic acid, a sulfur-containing diterpenoid derived from fetal calf serum, attenuates reactive oxygen species-induced oxidative stress in cultured striatal neurons","volume":"311","author":"Osakada","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.119223_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1134\/S0006297907060077","article-title":"Antioxidant and antiinflammatory activity of new water-soluble sulfur-containing phenolic compounds","volume":"72","author":"Zenkov","year":"2007","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2026.119223_bib26","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.1021\/jm300681r","article-title":"Discovery of a potential anti-ischemic stroke agent: 3-pentylbenzo[c]thiophen-1(3H)-one","volume":"55","author":"Wu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117474","article-title":"A brain-targeting dl-3-n-butylphthalide prodrug to treat ischemic stroke","volume":"290","author":"Han","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib28","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1039\/C9CC02829C","article-title":"Controllable thioester-based hydrogen sulfide slow-releasing donors as cardioprotective agents","volume":"55","author":"Yao","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.119223_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bcp.2017.11.014","article-title":"A review of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic applications","volume":"149","author":"Powell","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119223_bib30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.34133\/research.1107","article-title":"Hydrogen sulfide: a multitarget therapeutic for neuroinflammation in neurodegenerative diseases","volume":"9","author":"Zhang","year":"2026","journal-title":"Research"},{"key":"10.1016\/j.ejmech.2026.119223_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00755","article-title":"Black gas, bright future: H2S based therapeutics for neurodegenerative disorders","volume":"22","author":"Morris","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2026.119223_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0036-1589404","article-title":"Synthesis of enantioenriched phthalide and isoindolinone derivatives from 2-formylbenzoic acid","volume":"49","author":"Schreiner","year":"2016","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2026.119223_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104685","article-title":"Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease","volume":"109","author":"Liu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib34","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1021\/jm800259e","article-title":"Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors","volume":"51","author":"Cinelli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib35","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1016\/j.bmc.2016.06.010","article-title":"Synthesis and investigation of novel benzimidazole derivatives as antifungal agents","volume":"24","author":"Chandrika","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103707","article-title":"Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson's disease","volume":"97","author":"Li","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib37","first-page":"266","article-title":"New aspects of monoamine oxidase B inhibitors: the key role of halogens to open the golden door","volume":"28","author":"Bijo","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/DDDT.S236586","article-title":"Reversible small molecule inhibitors of MAO A and MAO B with anilide motifs","volume":"14","author":"Hagenow","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.119223_bib39","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.bmcl.2010.02.027","article-title":"Novel inhibitors of basal glucose transport as potential anticancer agents","volume":"20","author":"Zhang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119223_bib40","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1021\/acs.jmedchem.9b01886","article-title":"Stereoselective activity of 1-Propargyl-4-styrylpiperidine-like analogues that can discriminate between monoamine oxidase isoforms A and B","volume":"63","author":"Knez","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib41","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1021\/acs.jmedchem.4c02644","article-title":"Design of benzyl-triazolopyrimidine-based NADPH oxidase inhibitors leads to the discovery of a potent dual covalent NOX2\/MAOB inhibitor","volume":"68","author":"Noce","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib42","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acschemneuro.7b00050","article-title":"Indole-substituted benzothiazoles and benzoxazoles as selective and reversible MAO-B inhibitors for treatment of Parkinson's disease","volume":"8","author":"Nam","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119223_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118680","article-title":"Discovery of 3-benzyloxy-6-arylpyridazine derivatives as novel multi-target agents toward Parkinson's disease therapy","volume":"307","author":"Shi","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bioorg.2018.03.016","article-title":"Design, synthesis and evaluation of pterostilbene beta-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment","volume":"78","author":"Zheng","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib45","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1021\/acs.jmedchem.0c01663","article-title":"Computational fragment-based design facilitates discovery of potent and selective monoamine oxidase-B (MAO-B) inhibitor","volume":"63","author":"Jin","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/acsmedchemlett.1c00238","article-title":"Promising non-cytotoxic monosubstituted chalcones to target monoamine oxidase-B","volume":"12","author":"Iacovino","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119223_bib47","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and Coumarin analogs","volume":"50","author":"Binda","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103477","article-title":"Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: design, synthesis and biological evaluation","volume":"94","author":"Tian","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/cells8080911","article-title":"The therapeutic implications of tea polyphenols against dopamine (DA) neuron degeneration in Parkinson's disease (PD)","volume":"8","author":"Zhou","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119223_bib50","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1021\/jf500464k","article-title":"Synthesis of caffeic acid phenethyl ester derivatives, and their cytoprotective and neuritogenic activities in PC12 cells","volume":"62","author":"Shi","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104895","article-title":"Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents","volume":"111","author":"Ye","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118437","article-title":"Benzylpiperidine-pyridazin-3(2H)-one derivatives as potential multifunctional agents against Alzheimer's disease","volume":"303","author":"Shi","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib53","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3892\/etm.2021.10402","article-title":"Hispidin inhibits LPS-induced nitric oxide production in BV-2 microglial cells via ROS-dependent MAPK signaling","volume":"22","author":"Jin","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2026.119223_bib54","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bmc.2018.01.030","article-title":"Design, synthesis and evaluation of 4'-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer's disease treatment","volume":"26","author":"Cao","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/cns.13086","article-title":"Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4\/NF-kappaB signaling pathway","volume":"25","author":"Jin","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2026.119223_bib56","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm001020e","article-title":"High-throughput permeability pH profile and high-throughput alkane\/water log P with artificial membranes","volume":"44","author":"Wohnsland","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2016.01.003","article-title":"Investigation of salt formation between memantine and pamoic acid: its exploitation in nanocrystalline form as long acting injection","volume":"101","author":"Mittapelly","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejmech.2026.119223_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.928287","article-title":"The role of sulfur compounds in chronic obstructive pulmonary disease","volume":"9","author":"Jiang","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2026.119223_bib59","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1021\/acs.jmedchem.1c00578","article-title":"Optimization of N-phenylpropenoyl-l-amino acids as potent and selective inducible nitric oxide synthase inhibitors for Parkinson's disease","volume":"64","author":"Hu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/17460441.3.6.677","article-title":"Strategies to assess blood-brain barrier penetration","volume":"3","author":"Di","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119223_bib61","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.119223_bib62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2013.02.066","article-title":"The effect of dopamine on MPTP-induced rotarod disability","volume":"543","author":"Ayton","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2026.119223_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115417","article-title":"Design, synthesis, and SAR study of novel flavone 1,2,4-oxadiazole derivatives with anti-inflammatory activities for the treatment of Parkinson's disease","volume":"255","author":"Shen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119223_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbi.2017.07.159","article-title":"Impaired CBS-H2S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson's disease","volume":"67","author":"Yuan","year":"2018","journal-title":"Brain Behav. Immun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:03:37Z","timestamp":1793977417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":64,"alternative-id":["S0223523426006689"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119223","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of 6-benzyloxybenzo[c]thiophen-1(3H)-ones as selective monoamine oxidase-B inhibitors with antioxidant and anti-neuroinflammatory activities against Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119223"}}